205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Negative revenue growth while ADI stands at 0.06%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.56%
Negative EBIT growth while ADI is at 2.57%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.12%
Negative operating income growth while ADI is at 2.57%. Joel Greenblatt would press for urgent turnaround measures.
-12.95%
Negative net income growth while ADI stands at 2.70%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-12.96%
Negative EPS growth while ADI is at 3.83%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.15%
Negative diluted EPS growth while ADI is at 3.30%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.11%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-43.19%
Negative OCF growth while ADI is at 22.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-83.44%
Negative FCF growth while ADI is at 45.61%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
85.25%
10Y revenue/share CAGR under 50% of ADI's 212.59%. Michael Burry would suspect a lasting competitive disadvantage.
25.26%
5Y revenue/share CAGR under 50% of ADI's 55.74%. Michael Burry would suspect a significant competitive gap or product weakness.
35.02%
3Y revenue/share CAGR under 50% of ADI's 81.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
293.27%
10Y OCF/share CAGR at 50-75% of ADI's 432.76%. Martin Whitman might fear a structural deficiency in operational efficiency.
13.06%
Below 50% of ADI's 163.33%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.92%
3Y OCF/share CAGR under 50% of ADI's 192.06%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
475.86%
Net income/share CAGR 1.25-1.5x ADI's 338.49%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
35.51%
Below 50% of ADI's 160.94%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
49.34%
Below 50% of ADI's 242.45%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
69.87%
Below 50% of ADI's 405.62%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
55.24%
Below 50% of ADI's 156.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
102.31%
3Y equity/share CAGR at 75-90% of ADI's 126.93%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
491.84%
10Y dividend/share CAGR above 1.5x ADI's 154.38%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.55%
5Y dividend/share CAGR 1.25-1.5x ADI's 68.27%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
37.31%
3Y dividend/share CAGR similar to ADI's 40.54%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-0.95%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
19.26%
Inventory growth well above ADI's 8.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.40%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.45%
BV/share growth above 1.5x ADI's 1.19%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
11.53%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
4.84%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
10.49%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.